"description","uuid:ID","instanceType","id","name","text","label"
"Main objective","7924297d-b1f7-4afb-a613-443f4e942429","Objective","Objective_1","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).",""
"Safety","f831e78d-d257-4cb0-84e0-d1d5bf55d6fc","Objective","Objective_2","OBJ2","To document the safety profile of the xanomeline TTS.",""
"Behaviour","f6dc73f8-14c2-4b9b-b744-aa9b82c710d4","Objective","Objective_3","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.",""
